Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2020 Filed Feb 27, 2020 21:25 UTC |
Helsel Christopher PSr VP Chief Technology Officer
|
Grant2017 Plan Performance Share Units · Derivative | 16,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013417 · doc4.xml · derivative · entry 2 Helsel Christopher P · CIK 0001763728 · Sr VP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,798 Underlying: Common Stock · 16,798 shares Expires not disclosed F3 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:25 UTC |
Helsel Christopher PSr VP Chief Technology Officer
|
Grant2017 Plan Option · Derivative | 150,000 | $0.00 Strike: $10.12 | $0.00 |
DisclosureSEC source: 0001209191-20-013417 · doc4.xml · derivative · entry 1 Helsel Christopher P · CIK 0001763728 · Sr VP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-02-25 F1 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2017 Performance Plan. F2 · derivative.exercise_date: The option vests and becomes exercisable 50% on the third anniversary of the grant date and 100% on the fourth anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC |
Duda Laura PSR VP Global Communications
|
Grant2017 Plan Restricted Stock Units · Derivative | 13,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013415 · doc4.xml · derivative · entry 3 Duda Laura P · CIK 0001763990 · SR VP Global Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,339 Underlying: Common Stock · 13,339 shares Expires not disclosed F4 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F4 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F4 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F4 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC |
Duda Laura PSR VP Global Communications
|
Grant2017 Plan Performance Share Units · Derivative | 8,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013415 · doc4.xml · derivative · entry 2 Duda Laura P · CIK 0001763990 · SR VP Global Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,893 Underlying: Common Stock · 8,893 shares Expires not disclosed F3 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC |
Duda Laura PSR VP Global Communications
|
Grant2017 Plan Option · Derivative | 150,000 | $0.00 Strike: $10.12 | $0.00 |
DisclosureSEC source: 0001209191-20-013415 · doc4.xml · derivative · entry 1 Duda Laura P · CIK 0001763990 · SR VP Global Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-02-25 F1 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2017 Performance Plan. F2 · derivative.exercise_date: The option vests and becomes exercisable 50% on the third anniversary of the grant date and 100% on the fourth anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:22 UTC |
Delaney Christopher RPresident, EMEA
|
Grant2017 Plan Performance Share Units · Derivative | 53,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013414 · doc4.xml · derivative · entry 2 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,359 Underlying: Common Stock · 53,359 shares Expires not disclosed F3 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F3 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:22 UTC |
Delaney Christopher RPresident, EMEA
|
Grant2017 Plan Option · Derivative | 411,167 | $0.00 Strike: $10.12 | $0.00 |
DisclosureSEC source: 0001209191-20-013414 · doc4.xml · derivative · entry 1 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,167 Underlying: Common Stock · 411,167 shares Expires 2030-02-25 F1 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2017 Performance Plan. F2 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:21 UTC |
Bellissimo JonathanSR VP Global Operations & Tech
|
Grant2017 Plan Restricted Stock Units · Derivative | 20,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013412 · doc4.xml · derivative · entry 2 Bellissimo Jonathan · CIK 0001764022 · SR VP Global Operations & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,009 Underlying: Common Stock · 20,009 shares Expires not disclosed F2 · security: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F2 · derivative.exercise_price: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F2 · derivative.exercise_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. F2 · derivative.expiration_date: Restricted Stock Unit ("RSU") grant under the 2017 Performance Plan. The RSUs will vest and convert into shares of common stock three years from the date of grant on February 25, 2023. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:21 UTC |
Bellissimo JonathanSR VP Global Operations & Tech
|
Grant2017 Plan Performance Share Units · Derivative | 13,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013412 · doc4.xml · derivative · entry 1 Bellissimo Jonathan · CIK 0001764022 · SR VP Global Operations & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,339 Underlying: Common Stock · 13,339 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F1 · derivative.exercise_price: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F1 · derivative.exercise_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. F1 · derivative.expiration_date: Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:56 UTC |
Delaney Christopher RPresident, EMEA
|
Exercise / conversion2017 Plan Performance Shares · Derivative | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007186 · doc4.xml · derivative · entry 4 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.exercise_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.expiration_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:56 UTC |
Delaney Christopher RPresident, EMEA
|
Exercise / conversion2013 Plan Performance Shares · Derivative | 1,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007186 · doc4.xml · derivative · entry 3 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.exercise_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.expiration_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:56 UTC |
Delaney Christopher RPresident, EMEA
|
Tax withholdingCommon Stock | 1,176 | $13.45 | $15,817.20 |
DisclosureSEC source: 0001209191-20-007186 · doc4.xml · nonDerivative · entry 2 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,720 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:56 UTC |
Delaney Christopher RPresident, EMEA
|
Exercise / conversionCommon Stock | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007186 · doc4.xml · nonDerivative · entry 1 Delaney Christopher R · CIK 0001663064 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:08 UTC |
Scocos Evan MVice President and Controller
|
Exercise / conversion2013 Plan Performance Shares · Derivative | 399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007195 · doc4.xml · derivative · entry 4 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 399 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.exercise_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.expiration_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:08 UTC |
Scocos Evan MVice President and Controller
|
Tax withholdingCommon Stock | 143 | $13.45 | $1,923.35 |
DisclosureSEC source: 0001209191-20-007195 · doc4.xml · nonDerivative · entry 2 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,083 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:08 UTC |
Scocos Evan MVice President and Controller
|
Exercise / conversionCommon Stock | 399 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007195 · doc4.xml · nonDerivative · entry 1 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:06 UTC |
Patterson Ryan GPresident, Asia-Pacific Region
|
Exercise / conversion2017 Plan Performance Shares · Derivative | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007192 · doc4.xml · derivative · entry 3 Patterson Ryan G · CIK 0001717110 · President, Asia-Pacific Region 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 410 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.exercise_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F2 · derivative.expiration_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:06 UTC |
Patterson Ryan GPresident, Asia-Pacific Region
|
Tax withholdingCommon Stock | 196 | $13.45 | $2,636.20 |
DisclosureSEC source: 0001209191-20-007192 · doc4.xml · nonDerivative · entry 2 Patterson Ryan G · CIK 0001717110 · President, Asia-Pacific Region 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,367 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:06 UTC |
Patterson Ryan GPresident, Asia-Pacific Region
|
Exercise / conversionCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007192 · doc4.xml · nonDerivative · entry 1 Patterson Ryan G · CIK 0001717110 · President, Asia-Pacific Region 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:01 UTC |
McClellan Stephen RPresident, Americas
|
Exercise / conversion2013 Plan Performance Shares · Derivative | 2,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007188 · doc4.xml · derivative · entry 4 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,731 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.exercise_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.expiration_date: This Form 4 reports the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:01 UTC |
McClellan Stephen RPresident, Americas
|
Tax withholdingCommon Stock | 974 | $13.45 | $13,100.30 |
DisclosureSEC source: 0001209191-20-007188 · doc4.xml · nonDerivative · entry 2 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,112 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:01 UTC |
McClellan Stephen RPresident, Americas
|
Exercise / conversionCommon Stock | 2,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007188 · doc4.xml · nonDerivative · entry 1 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:58 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Exercise / conversion2013 Plan Performance Shares · Derivative | 13,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007187 · doc4.xml · derivative · entry 4 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.exercise_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. F3 · derivative.expiration_date: This Form 4 represents the conversion of 22% of the base number of Units granted, payable 100% in common stock. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:58 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Tax withholdingCommon Stock | 4,183 | $13.45 | $56,261.35 |
DisclosureSEC source: 0001209191-20-007187 · doc4.xml · nonDerivative · entry 2 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,414 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 21:58 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Exercise / conversionCommon Stock | 13,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007187 · doc4.xml · nonDerivative · entry 1 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:15 UTC |
Williams ThomasDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-002017 · doc4.xml · derivative · entry 1 Williams Thomas L · CIK 0001320730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,144 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:13 UTC |
Wessel MichaelDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-002013 · doc4.xml · derivative · entry 1 Wessel Michael · CIK 0001346244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,564 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:12 UTC |
WEIDEMEYER THOMAS HDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-002010 · doc4.xml · derivative · entry 1 WEIDEMEYER THOMAS H · CIK 0001227740 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,564 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:11 UTC |
STREETER STEPHANIE ADirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-002004 · doc4.xml · derivative · entry 1 STREETER STEPHANIE A · CIK 0001021762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,298 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:08 UTC |
Siu Hera KDirector
|
GrantRestricted Stock Units · Derivative | 717 | $15.38 | $11,027.46 |
DisclosureSEC source: 0001209191-20-001994 · doc4.xml · derivative · entry 1 Siu Hera K · CIK 0001796462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717 Underlying: Common Stock · 717 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:07 UTC |
PALMORE RODERICK ADirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001985 · doc4.xml · derivative · entry 1 PALMORE RODERICK A · CIK 0001218964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,179 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:05 UTC |
MCGLADE JOHN EDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001979 · doc4.xml · derivative · entry 1 MCGLADE JOHN E · CIK 0001265896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:03 UTC |
MCCOLLOUGH W ALANDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001972 · doc4.xml · derivative · entry 1 MCCOLLOUGH W ALAN · CIK 0001209891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,564 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:01 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001962 · doc4.xml · derivative · entry 1 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,538 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:00 UTC |
HELLMAN PETER SDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001953 · doc4.xml · derivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,433 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:58 UTC |
Geissler WernerDirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001939 · doc4.xml · derivative · entry 1 Geissler Werner · CIK 0001402226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,890 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:57 UTC |
FIRESTONE JAMES ADirector
|
GrantRestricted Stock Units · Derivative | 2,357 | $15.38 | $36,250.66 |
DisclosureSEC source: 0001209191-20-001934 · doc4.xml · derivative · entry 1 FIRESTONE JAMES A · CIK 0001207838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,564 Underlying: Common Stock · 2,357 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:46 UTC |
MCGLADE JOHN EDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052283 · doc4.xml · derivative · entry 1 MCGLADE JOHN E · CIK 0001265896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,231 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:39 UTC |
HELLMAN PETER SDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052251 · doc4.xml · derivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,451 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:57 UTC |
Williams ThomasDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052325 · doc4.xml · derivative · entry 1 Williams Thomas L · CIK 0001320730 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:55 UTC |
Wessel MichaelDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052318 · doc4.xml · derivative · entry 1 Wessel Michael · CIK 0001346244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,373 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:53 UTC |
WEIDEMEYER THOMAS HDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052313 · doc4.xml · derivative · entry 1 WEIDEMEYER THOMAS H · CIK 0001227740 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,373 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:51 UTC |
STREETER STEPHANIE ADirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052305 · doc4.xml · derivative · entry 1 STREETER STEPHANIE A · CIK 0001021762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,110 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:48 UTC |
PALMORE RODERICK ADirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052297 · doc4.xml · derivative · entry 1 PALMORE RODERICK A · CIK 0001218964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,378 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:43 UTC |
MCCOLLOUGH W ALANDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052271 · doc4.xml · derivative · entry 1 MCCOLLOUGH W ALAN · CIK 0001209891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,373 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:41 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 1,638 | $14.12 | $23,128.56 |
DisclosureSEC source: 0001209191-19-052262 · doc4.xml · derivative · entry 2 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,417 Underlying: Common Stock · 1,638 shares Expires not disclosed F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:41 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052262 · doc4.xml · derivative · entry 1 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,912 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:38 UTC |
Geissler WernerDirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052240 · doc4.xml · derivative · entry 1 Geissler Werner · CIK 0001402226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,944 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:36 UTC |
FIRESTONE JAMES ADirector
|
GrantRestricted Stock Units · Derivative | 2,567 | $14.12 | $36,246.04 |
DisclosureSEC source: 0001209191-19-052235 · doc4.xml · derivative · entry 1 FIRESTONE JAMES A · CIK 0001207838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,373 Underlying: Common Stock · 2,567 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| September 20, 2019 Filed Sep 24, 2019 21:10 UTC |
WELLS DARREN RExecutive VP and CFO
|
Exercise / conversion2017 Plan Restricted Stock Units · Derivative | 12,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050560 · doc4.xml · derivative · entry 3 WELLS DARREN R · CIK 0001190977 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted on September 20, 2018. F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted on September 20, 2018. F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted on September 20, 2018. F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted on September 20, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.